ジョージア州における子宮内膜がんの臨床試験
ジョージア州内の拠点で、子宮内膜がんに関する24件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Winship Cancer Institute of Emory University, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- 他2件
被験者募集中第3相
18歳以上 · 女性 · 2026/10/02更新 · NCT07198074A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Emory Winship Cancer Institute, Atlanta
- Augusta University, Augusta
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Piedmont Healthcare, Atlanta
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/29更新 · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Augusta University Medical Center, Augusta
被験者募集中第2相
18歳以上 · 女性 · 2026/09/28更新 · NCT05112601Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Piedmont Hospital, Atlanta
- 他3件
被験者募集中第2相
18歳以上 · 女性 · 2026/09/24更新 · NCT05640999A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- St. Joseph's/Candler Health System ( Site 6021), Savannah
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT06952504Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Georgia Cancer Center at Augusta University, Augusta
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Emory Winship Cancer Inst., Atlanta
- Emory Winship Cancer Inst., Atlanta
- Northside Hospital Atlanta, Atlanta
- 他1件
被験者募集中第3相
18歳以上 · 女性 · 2026/09/09更新 · NCT07166094A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Emory University, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
被験者募集中第1相
15歳以上 · 全性別 · 2026/08/25更新 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Emory University, Atlanta
被験者募集中第2相
18歳以上 · 女性 · 2026/08/21更新 · NCT05548296A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Winship Cancer Institute of Emory University, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT04104776Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Augusta University Georgia Cancer Center, Augusta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05377996A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Georgia Cancer Center, Augusta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04300556cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- North Georgia Health System, Gainesville
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
- Augusta University, Augusta
被験者募集中第2相
18歳〜70歳 · 女性 · 2025/10/30更新 · NCT06481592SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Beta-only IL-2 ImmunoTherapY Study
- Emory - Winship Cancer Institute, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Northside Hospital, Atlanta
- St. Joseph, Savannah
被験者募集中第2/3相
18歳以上 · 女性 · 2024/05/02更新 · NCT05797831ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。